BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 38310403)

  • 1. Comparison of Disease Phenotype and Course among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East.
    Vosoghinia H; Saberzadeh-Ardestani B; Anushiravani A; Mansour-Ghanaei F; Fakheri H; Vahedi H; Sheikhesmaeili F; Yazdanbod A; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Malekzadeh M; Kasaeian A; Alatab S; Sadeghi A; Kolahdoozan S; Amani M; Saberhosseini SN; Rayatpisheh M; Ahadi M; Colombel JF; Ungaro RC; Sima AR; Malekzadeh R
    Arch Iran Med; 2023 Sep; 26(9):481-488. PubMed ID: 38310403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
    Saberzadeh-Ardestani B; Anushiravani A; Mansour-Ghanaei F; Fakheri H; Vahedi H; Sheikhesmaeili F; Yazdanbod A; Moosavy SH; Vosoghinia H; Maleki I; Nasseri-Moghaddam S; Khosravi B; Malekzadeh M; Kasaeian A; Alatab S; Sadeghi A; Kolahdoozan S; Rayatpisheh M; Sima AR; Malekzadeh R
    Inflamm Bowel Dis; 2022 Jul; 28(7):1004-1011. PubMed ID: 34417824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
    Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
    Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium.
    Banerjee R; Pal P; Hilmi I; Ghoshal UC; Desai DC; Rahman MM; Dutta U; Mohiuddin SA; Al Mohannadi M; Philip M; Ramesh GN; Niriella MA; De Silva AP; de Silva HJ; Pisespongsa P; Limsrivilai J; Aniwan S; Nawarathne M; Fernandopulle N; Aye TT; Ni N; Al Awadhi S; Joshi N; Ngoc PTV; Kieu TV; Nguyen AD; Abdullah M; Ali E; Zeid A; Sollano JD; Saberi B; Omar M; Mohsin MN; Aftab H; Wai TM; Shastri YM; Chaudhuri S; Ahmed F; Bhatia SJ; Travis SPL;
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1004-1015. PubMed ID: 35178742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very-early-onset inflammatory bowel disease versus late-onset inflammatory bowel disease in relation to clinical phenotype: A cross-sectional study.
    Mansour HH; Seddek SS; Meguid MEAEL; Eskander AE; Galal ST
    Indian J Gastroenterol; 2023 Apr; 42(2):185-191. PubMed ID: 37166697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
    Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
    Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Jeuring SF; van den Heuvel TR; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
    Inflamm Bowel Dis; 2016 Jun; 22(6):1425-34. PubMed ID: 26933752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.
    Kariyawasam VC; Kim S; Mourad FH; Selinger CP; Katelaris PH; Brian Jones D; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Pathirana PW; Leong RW
    Inflamm Bowel Dis; 2019 Jul; 25(8):1390-1398. PubMed ID: 30597066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study.
    Niriella MA; Liyanage IK; Kodisinghe SK; De Silva AP; Jayatissa AVGAM; Navarathne NMM; Peiris RK; Kalubovila UP; Kumarasena SR; Jayasekara RW; de Silva HJ
    BMC Gastroenterol; 2021 Feb; 21(1):71. PubMed ID: 33593289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.
    Oxford EC; Nguyen DD; Sauk J; Korzenik JR; Yajnik V; Friedman S; Ananthakrishnan AN
    Am J Gastroenterol; 2013 Jul; 108(7):1123-9. PubMed ID: 23419379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease in Iran: a review of 457 cases.
    Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum and trend of pediatric inflammatory bowel disease: A two-decade experience from northern India.
    Mohan N; Deswal S; Bhardwaj A
    Indian J Gastroenterol; 2024 Feb; 43(1):208-214. PubMed ID: 37943479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.
    Conway G; Velonias G; Andrews E; Garber JJ; Yajnik V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2017 Mar; 45(6):814-823. PubMed ID: 28105709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.